Kalkine HealthCare Portfolio Performance Methodology

• Recommendations under Kalkine's HealthCare Portfolio (Hypothetical), started from year 2020-2021 (for instance period from February 3, 2020, till January 29, 2021), have been used for the calculations purpose.
• Generally speaking, Kalkine HealthCare Portfolio represents a hypothetical portfolio, and this consists of stocks that appear to be providing good value while commanding decent valuations and investors can benefit from returns from high growth businesses. This category may include speculative stocks expected to have growth prospects but carry some defined cited risks.
• Our Portfolio is hypothetical, and our performance figures are based on recommendations from Kalkine HealthCare Reports using stock prices at the date of publication.
• It is also prudent to note that performance of stocks included in Kalkine HealthCare Portfolio (Hypothetical) has been calculated based on their price values during the specific time period in order to give ‘as-on-date’ performance picture. 
• Where a stock has been recommended multiple-times, the average price is taken into consideration. We might need to provide update on a stock several times during a year or for the length of coverage and for that reason the average BUY price is taken into consideration. 
• Performance figures quoted do not take into account transaction fees and charges. The profits or losses are hypothetical and include dividends or distribution for the length of the coverage until the recommendation is designated as closed. 
• All investors are advised to conduct their own independent research into individual stocks recommended by Kalkine before making a purchase decision. In addition, investors are advised that past stock performance is no guarantee of future price appreciation.
• We encourage you to think of investing as a long-term pursuit.

Note: For any benchmark index return, proportional dividend yields have been taken onto account as per the information available.